🇺🇸 FDA

Intelligence · Clinical Pipeline

Phase II Pipeline Programs

Proof-of-concept and dose-finding clinical programs in Phase II development.

Programs
7,238

Quick answer

NovaPharmaNews tracks 7,238 phase ii pharmaceutical pipeline programs from ClinicalTrials.gov. Proof-of-concept and dose-finding clinical programs in Phase II development.

Top sponsors

Page 120 of 151

  1. Softisan 378, Cannabidiol

    Disc Medicine

    psychological disorders: PTSD; Anxiety disorders

    phase 2 small molecule active

    1 trial

  2. Sogroya 5 mg/1.5 mL solution for injection in pre-filled pen, Sogroya 10 mg/1.5 mL solution for injection in pre-filled pen, Sogroya 15 mg/1.5 mL solution for injection in pre-filled pen, Norditropin FlexPro, injektionsvæske, opløsning i fyldt pen

    NovoThirteen

    SGA - small for gestational age children

    phase 2 small molecule active

    1 trial

  3. Solabegron

    GlaxoSmithKline

    Overactive Bladder

    phase 2 small molecule completed

    1 trial

  4. Solriamfetol

    Axsome Therapeutics

    Multiple Sclerosis

    phase 2 small molecule active

    1 trial

  5. Solution for injection in pre-filled syringe

    Alphapharm Pty Ltd

    Short Bowel Syndrome-associated Intestinal Failure (SBS-IF)

    phase 2 small molecule active

    1 trial

  6. Sonelokimab

    MoonLake Immunotherapeutics

    axial spondyloarthritis

    phase 2 small molecule active

    1 trial

  7. Sonelokimab

    MoonLake Immunotherapeutics

    Palmoplantar Pustulosis

    phase 2 small molecule active

    1 trial

  8. Sonelokimab (M1095)

    MoonLake Immunotherapeutics

    Hidradenitis Suppurativa

    phase 2 small molecule completed

    1 trial

  9. SonoVue 8 microlitres/mL powder and solvent for dispersion for injection, CARBOPLATIN

    Pari Pharma GmbH

    recurrent primary supratentorial malignant brain tumors in children

    phase 2 small molecule active

    1 trial

  10. Sonodynamic therapy(SDT)

    The First People's Hospital of Lianyungang

    Peripheral Arterial Disease

    phase 2 other terminated

    1 trial

  11. Sonrotoclax

    BEONE MEDICINES AUS PTY LTD

    Waldenstrom Macroglobulinemia

    phase 2 small molecule active

    1 trial

  12. Sonrotoclax

    BEONE MEDICINES AUS PTY LTD

    Relapsed/Refractory Multiple Myeloma

    phase 2 small molecule active

    1 trial

  13. Soquelitinib

    Corvus Pharmaceuticals

    Atopic Dermatitis

    phase 2 small molecule active

    2 trials

  14. Sorafenib

    United Therapeutics Europe Ltd

    Lung Cancer

    phase 2 small molecule completed

    1 trial

  15. Sorafenib (Nexavar, BAY43-9006) plus Doxorubicin

    Bayer HealthCare AG

    Carcinoma, Hepatocellular

    phase 2 small molecule completed

    1 trial

  16. Sotagliflozin

    LEXICON PHARMACEUTICALS, INC.

    Type 1 Diabetes

    phase 2 small molecule active

    2 trials

  17. Sotagliflozin

    LEXICON PHARMACEUTICALS, INC.

    Cardiac Failure Aggravated

    phase 2 small molecule terminated

    1 trial

  18. Soticlestat

    Takeda

    Epilepsy

    phase 2 small molecule terminated

    1 trial

  19. Soticlestat

    Takeda

    15q Duplication Syndrome

    phase 2 small molecule completed

    1 trial

  20. Soticlestat

    Takeda

    Complex Regional Pain Syndrome

    phase 2 small molecule completed

    1 trial

  21. Sotrovimab

    Vir Biotechnology

    COVID-19

    phase 2 mab terminated

    1 trial

  22. Sotrovimab (Gen1)

    Vir Biotechnology

    Covid19

    phase 2 mab completed

    1 trial

  23. Sparsentan

    Travere Therapeutics

    ANCA Associated Vasculitis

    phase 2 small molecule active

    1 trial

  24. Sparsentan_DF3, Sparsentan_DF2, Sparsentan_DF4

    Travere Therapeutics

    Proteinuric glomerular diseases including: •Focal segmental glomerulosclerosis (FSGS) •Minimal change disease (MCD) •Immunoglobulin A nephropathy (IgAN) •Immunoglobulin A vasculitis (IgAV) •Alport syndrome (AS)

    phase 2 small molecule active

    1 trial

  25. Spermidine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Radiation-induced Xerostomia

    phase 2 small molecule active

    1 trial

  26. Spesolimab

    Boehringer Ingelheim

    Generalized Pustular Psoriasis

    phase 2 small molecule active

    1 trial

  27. Spironolactone 25mg

    Hospital Authority, Hong Kong

    Atrial Fibrillation

    phase 2 small molecule active

    1 trial

  28. Splinting

    United Therapeutics Europe Ltd

    Hand Osteoarthritis

    phase 2 other completed

    1 trial

  29. Spray of spirulina derivatives

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Radiation-induced Oral Mucositis

    phase 2 small molecule active

    1 trial

  30. Stanate

    Mallinckrodt Pharmaceuticals Ireland Limited

    Hyperbilirubinemia

    phase 2 small molecule completed

    1 trial

  31. Standard Cognitive Behavioral Treatment

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    phase 2 other completed

    1 trial

  32. Standard Treatment As Usual (TAU)

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Abuse

    phase 2 other completed

    1 trial

  33. Standard drug counseling

    BRIGHT MINDS BIOSCIENCES INC.

    Opiate Dependence

    phase 2 other completed

    1 trial

  34. Standard intervention (counseling + self-help written materials)

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use

    phase 2 other completed

    1 trial

  35. Standard lymphodepletion regimen

    Kyverna Therapeutics

    Stiff-Person Syndrome

    phase 2 mab active

    1 trial

  36. Standard of Care with Lofexidine

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Withdrawal (Disorder)

    phase 2 small molecule active

    1 trial

  37. Standard of care and PrEP Choice at Enrollment

    BRIGHT MINDS BIOSCIENCES INC.

    HIV

    phase 2 other active

    1 trial

  38. Stellate Ganglion Block injection with ropivicane

    United Therapeutics Europe Ltd

    Post Traumatic Stress Disorder (PTSD)

    phase 2 other completed

    1 trial

  39. Stem Cell Educator

    The First People's Hospital of Lianyungang

    Alopecia Areata

    phase 2 other active

    1 trial

  40. Stem cell infusion

    Lxo Ireland Designated Activity Company

    Critical Limb Ischemia (CLI)

    phase 2 small molecule terminated

    1 trial

  41. Stem cells

    Takeda

    Rheumatoid Arthritis Aggravated

    phase 2 gene therapy completed

    1 trial

  42. Steroids switch

    United Therapeutics Europe Ltd

    Prostate Cancer

    phase 2 small molecule completed

    1 trial

  43. Stivarga 40 mg film-coated tablets

    Ningbo Cancer Hospital

    Bone sarcoma

    phase 2 small molecule active

    1 trial

  44. Stivarga 40 mg film-coated tablets

    Istituto Gentili S.r.l.

    grade 1, 2 and 3 meningioma

    phase 2 small molecule active

    1 trial

  45. Stivarga 40 mg film-coated tablets, Tevimbra 100 mg concentrate for solution for infusion, OMTX705

    Lacuna Pharma Pty Ltd

    Advanced/metastatic colorectal cancer

    phase 2 small molecule active

    1 trial

  46. Streptococcus salivarius K12

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Head and Neck Squamous Cell Carcinoma

    phase 2 small molecule completed

    1 trial

  47. Stromal-vascular fraction

    Century Therapeutics

    Knee Osteoarthritis

    phase 2 mab active

    1 trial

  48. Study 3: Chronic care management

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking, Tobacco

    phase 2 other completed

    1 trial

Frequently asked questions

How many Phase II pipeline programs are in the directory?

7,238 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.